BRPI0414267A - polipeptìdeos de campilobacter e métodos de uso - Google Patents

polipeptìdeos de campilobacter e métodos de uso

Info

Publication number
BRPI0414267A
BRPI0414267A BRPI0414267-5A BRPI0414267A BRPI0414267A BR PI0414267 A BRPI0414267 A BR PI0414267A BR PI0414267 A BRPI0414267 A BR PI0414267A BR PI0414267 A BRPI0414267 A BR PI0414267A
Authority
BR
Brazil
Prior art keywords
methods
polypeptides
treating
present
campylobacter
Prior art date
Application number
BRPI0414267-5A
Other languages
English (en)
Inventor
Darren E Straub
Daryll A Emery
Original Assignee
Epitopix Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitopix Llc filed Critical Epitopix Llc
Publication of BRPI0414267A publication Critical patent/BRPI0414267A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"POLIPEPTìDEOS DE CAMPILOBACTER E MéTODOS DE USO". A presente invenção polipeptídeos regulados por metal, isolados, obteníveis de um Campylobacter spp., e composições que incluem os polipeptídeos. A presente invenção também inclui métodos para usar as composições descritas no presente, incluindo métodos para tratar uma infecção em um indivíduo, para tratar uma doença causada por um Campylobacter spp., e para diminuir a colonização de um animal.
BRPI0414267-5A 2003-09-19 2004-09-20 polipeptìdeos de campilobacter e métodos de uso BRPI0414267A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50411903P 2003-09-19 2003-09-19
PCT/US2004/030873 WO2005028665A2 (en) 2003-09-19 2004-09-20 Campylobacter polypeptides and methods of use

Publications (1)

Publication Number Publication Date
BRPI0414267A true BRPI0414267A (pt) 2006-11-21

Family

ID=34375448

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414267-5A BRPI0414267A (pt) 2003-09-19 2004-09-20 polipeptìdeos de campilobacter e métodos de uso

Country Status (9)

Country Link
US (10) US8119147B2 (pt)
EP (1) EP1678316B1 (pt)
AT (1) ATE520709T1 (pt)
AU (1) AU2004274977B2 (pt)
BR (1) BRPI0414267A (pt)
CA (1) CA2539074C (pt)
ES (1) ES2395022T3 (pt)
NZ (2) NZ582566A (pt)
WO (1) WO2005028665A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
WO1995021627A1 (en) * 1994-02-09 1995-08-17 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
NZ526786A (en) * 2001-01-03 2006-02-24 Willmar Poultry Co Inc Methods for removal of lipopolysaccharides (LPS) from vaccines for non-human animals
CA2339436A1 (fr) 2001-03-15 2002-09-15 Josee Harel Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
NZ582566A (en) 2003-09-19 2010-11-26 Epitopix Llc Metal regulated polypeptides and methods of use from campylobacter spp.
MX2007001886A (es) * 2004-08-25 2007-04-24 Epitopix Llc Polipeptidos de fusobacteria y metodos de uso.
WO2006079076A2 (en) 2005-01-21 2006-07-27 Epitopix, Llc Yersinia spp. polypeptides and methods of use
CA2597263C (en) 2005-02-14 2017-01-17 Epitopix, Llc Polypeptides from staphylococcus aureus and methods of use
GB0720250D0 (en) 2007-10-17 2007-11-28 Univ Edinburgh Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof
BRPI1011856A2 (pt) 2009-03-23 2020-11-03 Epitopix, Llc polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso
WO2012025831A2 (en) * 2010-08-24 2012-03-01 The University Of British Columbia Salmonella vaccine proteins
AU2012261953A1 (en) 2011-06-03 2013-12-12 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
WO2013009843A1 (en) * 2011-07-11 2013-01-17 Camas Incorporated Compositions against bacterial toxins
US8753643B1 (en) 2012-04-11 2014-06-17 Life-Science Innovations, Llc Spray dried compositions and methods of use
EP2970494B1 (en) 2013-03-14 2017-12-13 The Board of Regents of The University of Texas System Her3 specific monoclonal antibodies for diagnostic and therapeutic use
JP6431486B2 (ja) * 2013-12-26 2018-11-28 株式会社カネカ 太陽電池のｉ‐ｖ測定方法、太陽電池のｉ‐ｖ測定装置、太陽電池の製造方法、太陽電池モジュールの製造方法、および太陽電池モジュール
WO2016135627A1 (es) * 2015-02-26 2016-09-01 Universidad De Los Andes Péptidos derivados de ompa de e. coli y procedimiento de identificación y obtención de los mismos.
CA2991907A1 (en) * 2015-07-10 2017-01-19 Douglas T. Burkhardt Proteins and immunizing compositions containing klebsiella proteins and methods of use
BR112018009319A8 (pt) 2015-11-09 2019-02-26 Epitopix Llc polipeptídeos de fusobacterium e métodos de uso
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
AU2018304469B2 (en) 2017-07-20 2023-04-06 Spogen Biotech Inc. Bioactive polypeptides for improvements in plant protection, growth and productivity
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
JP2020031557A (ja) * 2018-08-28 2020-03-05 株式会社日立ハイテクノロジーズ 生体分子分析装置
US11082452B2 (en) * 2018-10-15 2021-08-03 Paypal, Inc. Multi-dimensional drift nuance intelligence threat engine

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003792A (en) * 1967-07-01 1977-01-18 Miles Laboratories, Inc. Conjugates of acid polysaccharides and complex organic substances
US4033792A (en) * 1974-12-23 1977-07-05 United Technologies Corporation Composite single crystal article
US4167560A (en) 1977-04-12 1979-09-11 Texas Vet Lab, Inc. Polyvalent shipping fever vaccine
US4748018A (en) 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US4530963A (en) 1982-08-20 1985-07-23 Devoe-Holbein International, N.V. Insoluble chelating compositions
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US4871488A (en) 1985-04-22 1989-10-03 Albany Medical College Of Union University Reconstituting viral glycoproteins into large phospholipid vesicles
US4663161A (en) 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions
US4681761A (en) 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
US4981685A (en) 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
EP0287206B2 (en) 1987-03-24 1999-11-24 BTG INTERNATIONAL LIMITED (Company No. 2664412) Vaccine against pasteurella
US5885589A (en) 1988-04-12 1999-03-23 Intervet International B.V. Pasteurella vaccine
FR2644346B1 (fr) 1989-03-20 1994-05-13 Rhone Merieux Vaccins contre les bacteries septicemiques, preparations d'antigenes de bacteries septicemiques, nouvelles bacteries et vecteurs pour la preparation de ces antigenes ou vaccins
US5141743A (en) 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
US5292869A (en) 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
AU4114893A (en) 1992-04-27 1993-11-29 Michigan State University Method for producing a bacterial vaccine and novel vaccines produced thereby
US5578314A (en) 1992-05-29 1996-11-26 The Regents Of The University Of California Multiple layer alginate coatings of biological tissue for transplantation
US5534256A (en) 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
US5439808A (en) 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5830479A (en) 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
WO1995021627A1 (en) 1994-02-09 1995-08-17 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US5663004A (en) * 1994-02-15 1997-09-02 Xerox Corporation Recording sheets containing mildew preventing agents
WO1995025742A1 (en) 1994-03-22 1995-09-28 Pfizer Inc. Pasteurellaceae antigens and related vaccines
US5538733A (en) 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US5679564A (en) 1994-10-05 1997-10-21 Antex Biologics, Inc. Methods for producing enhanced antigenic campylobacter bacteria and vaccines
US6121037A (en) 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
US6048539A (en) 1995-11-02 2000-04-11 Connaught Laboratories Limited Lactoferrin receptor protein
US5777324A (en) 1996-09-19 1998-07-07 Sequenom, Inc. Method and apparatus for maldi analysis
DE19803453A1 (de) 1998-01-30 1999-08-12 Boehringer Ingelheim Int Vakzine
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
JP2000351735A (ja) 1999-04-09 2000-12-19 Akzo Nobel Nv カンピロバクターワクチン
US20070259007A1 (en) * 1999-10-19 2007-11-08 Kruzel Marian L Lactoferrin: an adjuvant for vaccines
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
KR20020097200A (ko) 2000-03-21 2002-12-31 엘리트라 파마슈티컬즈, 인코포레이티드 원핵세포에서의 필수유전자의 동정
US7851212B2 (en) * 2000-05-10 2010-12-14 Sanofi Pasteur Limited Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
AT410173B (de) 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
NZ526786A (en) 2001-01-03 2006-02-24 Willmar Poultry Co Inc Methods for removal of lipopolysaccharides (LPS) from vaccines for non-human animals
AT410798B (de) 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
AU2002353764A1 (en) 2001-06-17 2003-03-18 D-Squared Biotechnologies, Inc. Staphylococci surface-exposed immunogenic polypeptides
US6720160B2 (en) 2001-10-11 2004-04-13 Helica Biosystems, Inc. Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
CN1261398C (zh) * 2001-10-31 2006-06-28 旭硝子株式会社 含氟二烯化合物及其制造方法
ES2537737T3 (es) 2002-08-02 2015-06-11 Glaxosmithkline Biologicals S.A. Composiciones de vacuna que comprenden lipooligosacáridos de inmunotipo L2 y/o L3 de Neisseria meningitidis de IgtB
WO2004030699A1 (en) 2002-10-03 2004-04-15 Intercell Ag Use of molecules which interact with the haptoglobin receptor ligand binding
US20050106159A1 (en) * 2003-08-12 2005-05-19 Thompson Stuart A. Campylobacter jejuni outer membrane protein immunogenic composition
NZ582566A (en) 2003-09-19 2010-11-26 Epitopix Llc Metal regulated polypeptides and methods of use from campylobacter spp.
EP1740604A2 (en) 2004-04-27 2007-01-10 Intercell AG Td antigens
WO2006079076A2 (en) 2005-01-21 2006-07-27 Epitopix, Llc Yersinia spp. polypeptides and methods of use
CA2597263C (en) 2005-02-14 2017-01-17 Epitopix, Llc Polypeptides from staphylococcus aureus and methods of use
US7412743B2 (en) * 2006-08-07 2008-08-19 Chiang-Fen Lin Wiper for an automobile rear-view mirror

Also Published As

Publication number Publication date
US20120003269A1 (en) 2012-01-05
EP1678316B1 (en) 2011-08-17
NZ582566A (en) 2010-11-26
EP1678316A2 (en) 2006-07-12
US8329192B2 (en) 2012-12-11
US8119147B2 (en) 2012-02-21
US10086059B2 (en) 2018-10-02
ATE520709T1 (de) 2011-09-15
US9950052B2 (en) 2018-04-24
US9981026B2 (en) 2018-05-29
EP1678316A4 (en) 2007-06-27
WO2005028665A2 (en) 2005-03-31
US20050186217A1 (en) 2005-08-25
WO2005028665A3 (en) 2006-06-22
US9109028B2 (en) 2015-08-18
NZ546601A (en) 2010-07-30
AU2004274977B2 (en) 2011-06-23
US20160008450A1 (en) 2016-01-14
US20050095682A1 (en) 2005-05-05
CA2539074C (en) 2017-11-07
US20130071434A1 (en) 2013-03-21
US20170035872A1 (en) 2017-02-09
US9463230B2 (en) 2016-10-11
ES2395022T3 (es) 2013-02-07
US20170080072A1 (en) 2017-03-23
US20170080074A1 (en) 2017-03-23
US9943581B2 (en) 2018-04-17
US9925253B2 (en) 2018-03-27
AU2004274977A1 (en) 2005-03-31
US20100111903A1 (en) 2010-05-06
US20170080073A1 (en) 2017-03-23
CA2539074A1 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
BRPI0414267A (pt) polipeptìdeos de campilobacter e métodos de uso
HRP20181459T1 (hr) Humanizirani antagonisti anti-beta7 i njihove uporabe
TW200732349A (en) Anti-OX40L antibodies and methods using same
CY1109998T1 (el) Ενδυναμωτες υποδοχεων γλουταμινικου
DE60314500D1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
MY142777A (en) Substituted indole-o-glucosides
ATE380176T1 (de) Benzanilide als öffner des kaliumkanals
UA87991C2 (en) Substituted indole-o-glucosides
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
ZA200701656B (en) Humanized anti-cment antagonists
ATE515277T1 (de) Zusammensetzungen und verfahren zum beschichten von medizinischen implantaten
IL211367A0 (en) An antibody, a fragment thereof, a method of preparing the same and a use of the antibody
PT1353689E (pt) Composicoes imunizantes e metodos de utilizacao
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
TW200624426A (en) BACE inhibitors
TR200003384T2 (tr) Arginin türevleri kullanılarak oksazolidinon antibakteriyel maddelerin etkisinin arttırılması
DK1539724T3 (da) Aminobenzothiazolforbindelser med NOS-inhiberende aktivitet
TW200505896A (en) Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist
BRPI0414933A (pt) derivativos de imidazopiridina como inibidores de óxido nìtrico sintase induzìvel
SG166768A1 (en) Agonist anti-trkc antibodies and methods using same
TW200716088A (en) Formulations and methods for treating amyloidosis
MY147790A (en) Stable emulsion composition
ATE391489T1 (de) Haarbehandlungszusammensetzungen
BRPI0414972A (pt) derivados de imidazopiridinas como inibidores de no-sintase induzìvel
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 24 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.